Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development. (linkinghub.elsevier.com)

Authors: Chhan CB … McGuire AT Journal: Cell Reports Medicine Published: 2026-02-17 DOI: https://doi.org/10.1016/j.xcrm.2026.102618